Janney Montgomery Scott LLC Ab Cellera Biologics Inc. Transaction History
Janney Montgomery Scott LLC
- $38.3 Billion
- Q2 2025
A detailed history of Janney Montgomery Scott LLC transactions in Ab Cellera Biologics Inc. stock. As of the latest transaction made, Janney Montgomery Scott LLC holds 10,543 shares of ABCL stock, worth $45,018. This represents 0.0% of its overall portfolio holdings.
Number of Shares
10,543
Previous 13,043
19.17%
Holding current value
$45,018
Previous $29,000
24.14%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding ABCL
# of Institutions
148Shares Held
131MCall Options Held
156KPut Options Held
346K-
Baker Bros. Advisors LP New York, NY27.5MShares$118 Million0.73% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL15.7MShares$66.9 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA13.4MShares$57.1 Million0.01% of portfolio
-
Voya Investment Management LLC Atlanta, GA10.6MShares$45.4 Million0.03% of portfolio
-
Baillie Gifford & CO10.4MShares$44.2 Million0.03% of portfolio
About AbCellera Biologics Inc.
- Ticker ABCL
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 285,139,008
- Market Cap $1.22B
- Description
- AbCellera Biologics Inc. develops antibody discovery platform. Its full-stack, artificial intelligence-powered antibody discovery platform searches and analyzes the database of natural immune systems to find antibodies that could be developed as drugs. As of December 31, 2021, the company had 156 discovery programs that are either completed, in ...